Riskpilot← Back to searchSign inGet full accessCombimed AB
ABActiveOrg 5563656866Drottninggatan 50Business and other management consultancy activities · NACE 7020Est. 19892 employees
Revenue 2025
SEK 3,1M
+9% vs 2024
EBITDA margin
16.7%
+90% vs 2024
Equity ratio
28.5%
Financial strength
Net profit 2025
SEK 316K
+446% vs 2024
| Revenue | SEK 3,1M | +9% |
| EBITDA | SEK 517K | +90% |
| Net profit | SEK 316K | +446% |
| Total assets | SEK 3,8M | +3% |
| Equity | SEK 1,1M | +42% |
| Employees | 2 | — |
Legal name
Combimed AB
Org number
5563656866
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
7 juli 1989
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna suppleanten
Company purpose
Aktiebolaget ska köpa och sälja medicinsk utrustning och kläder för personal inom vård och omsorg samt sportartiklar. Handel och reparationer av verktygsmaskiner, fordon, fordonsdelar och fordonsrelaterade maskiner samt personaluthyrning. Inköp, försäljning, uppfödning samt utbildning av hästar.
Address
Drottninggatan 50
Email
linda@combimed.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 095 | 2 689 | 2 659 | 2 841 | 3 097 |
| Staff expenses | — | −996 | −1 036 | −1 080 | −1 244 |
| EBITDA | 336 | 219 | 290 | 272 | 517 |
| Depreciation & amort. | −59 | −73 | −73 | −70 | −61 |
| EBIT | 277 | 146 | 217 | 202 | 456 |
| Net financials | −65 | −63 | −72 | −81 | −54 |
| Profit before tax | 158 | 60 | 207 | 109 | 402 |
| Tax | −37 | −16 | −51 | −51 | −87 |
| Net profit | 121 | 44 | 156 | 58 | 316 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 903 | 3 843 | 3 879 | 3 632 | 3 758 |
| Equity | 682 | 666 | 822 | 754 | 1 070 |
| Long-term debt | 2 788 | 2 744 | 2 646 | 2 357 | 2 210 |
| Short-term debt | 274 | 251 | 291 | 387 | 345 |
| Total debt | 3 062 | 2 995 | 2 936 | 2 745 | 2 555 |
EBITDA margin
16.7%
This company
15.8%
Market median
+6% vs market
20212025
Equity ratio
28.5%
This company
38.2%
Market median
-25% vs market
20212025
Return on equity
29.5%
This company
18.4%
Market median
+60% vs market
20212025
Net profit margin
10.2%
This company
8.1%
Market median
+26% vs market
20212025
Asset turnover
0.82×
This company
1.12×
Market median
+27% vs market
20212025
Debt / equity
2.51×
This company
0.62×
Market median
-305% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2025 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Combimed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Linda Kerstin Karolina Aronsson | Chairman | 0 companies |
| Lars Arvid Viking Aronsson | Deputy Board Member | 0 companies |
| John Peter Bergermark | Board of Directors | 0 companies |
| Ester Monika Aronsson | Deputy Board Member | 0 companies |